GetWell Health PR Anonymous (not verified) Fri, 07/03/2026 - 11:01 Program Name GetWell Health PR Accepting Referrals from RH 1 Address 701 Ave. Ponce de Leon Suit 108-A San Juan , PR 00907 United States Geocoding Field POINT (-66.083423 18.456213) Phone 787-556-3021 Program Type DPPE Record Type 012Rk00000MXcjPIAT Delivery Mode In-person Extended Zip 0090 Accepts Medicare 0 Program Id DPPE-644 DP Alliance Program c 1
The American Diabetes Association Requests OMB Withdraw Proposed Rule Changing Guidelines for Federal Financial Assistance mcarmody Thu, 07/02/2026 - 18:03 Official Statement The American Diabetes Association Requests OMB Withdraw Proposed Rule Changing Guidelines for Federal Financial Assistance ARLINGTON, Va. July 2, 2026 Today, the American Diabetes Association ® (ADA) submitted its official public comment on the White House Office of Management and Budget (OMB) proposed rule on the Guidance for Federal Financial Assistance. In its comment, the ADA expressed significant concern over the…
In this episode, Chief Innovation Officer Dr. Ami Bhatt is joined by Dr. Sri Adusumalli to discuss the integration of large language models in health systems.
Meet Roe: Proving Type 1 Diabetes Can’t Stop a Division I Dream mseibold Thu, 07/02/2026 - 15:17 Type 1 Share Your Story By sharing your story, you help us raise awareness of diabetes so we can bend the curve on it once and for all. Will you help us awaken the world? Share Your Story
Current guidelines for management of atrial fibrillation (AF) recommend continuation of oral anticoagulation (OAC) following successful catheter ablation of AF for patients deemed at elevated thromboembolic risk.
New policy paper outlines recommendations to strengthen oversight and transparency of private equity and corporatization in healthcare and their effects on clinical autonomy and care delivery.
A novel sarcopenic obesity index served as a clinically meaningful predictor of cardiovascular risk and lent further insight into accompanying genetics and possible therapeutic targets, according to research published July 1 in JACC.
This poll included a clinical vignette of an 80-year-old man with atrial fibrillation (AF), high thromboembolic risk, and multiple cardiovascular (CV) comorbidities who presented 2 months after a spontaneous lobar intracerebral hemorrhage while receiving reduced-dose apixaban...
In this week’s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM).
The ACC's work in cardiovascular disease (CVD) prevention is entering an important new phase – one that reflects both the urgency of the challenge and the opportunity to deliver lasting impact.
Hippocrates is often credited with saying, "Let food be thy medicine, and medicine be thy food." Now, modern day research is proving there is truth to this ancient wisdom.
A new ACC Expert Consensus Decision Pathway (ECDP) addressing "Optimization of Postpartum Care for Patients With and at Risk for Premature and Long-Term Cardiovascular (CV) Disease" provides recommended strategies for successful postpartum cardiovascular care...
Until the ACC/AHA guideline on the management of acute pulmonary embolism (PE) was published in February, more than a decade had passed since the last one. During this interval, catheter-based interventions have expanded substantially, reshaping management of intermediate-risk PE.
Mitral annular calcification (MAC), which can produce mitral regurgitation (MR), mitral stenosis or both, is among the most challenging conditions to manage in cardiovascular medicine due to anatomic and patient complexity.
Cardiac electrophysiology (EP) is evolving quickly and data presented this year at ACC.26, European Heart Rhythm Association (EHRA 2026) and Heart Rhythm Society (HRS 2026) suggest practice may change just as fast.
A middle-aged man with volume overload, diabetes and elevated transferrin saturation. An elderly woman with severe tricuspid regurgitation, worsening abdominal bloating and dyspnea on exertion. An elderly man with left ventricular hypertrophy, carpal tunnel syndrome and hypotension despite guideline-directed medical therapy.
The ACC has announced a new Cardiogenic Shock Designation to improve outcomes for one of the most life-threatening complications of myocardial infarction. The new designation builds on the success of the ACC Chest Pain Center Accreditation, which has helped hospitals standardize and improve care...
Earlier intervention and lower goals for LDL-C are key recommendations in the ACC/AHA Dyslipidemia Guideline, published in March – recognizing the risks of prolonged exposure to dyslipidemia leading to atherosclerotic cardiovascular disease (ASCVD).
TAVR and surgery demonstrated comparable and sustained valve durability in low-risk patients with symptomatic severe aortic stenosis (AS), with both approaches showing low and similar rates of structural valve deterioration (SVD), all-cause bioprosthetic valve failure (BVF) and reintervention through seven years...
Sugar-sweetened beverages (SSBs) and fruit juice consumption were positively associated with a higher risk of hypertension independent of diet quality, physical activity and other factors, according to results from the ongoing GUTS study published June 22 in Circulation.
There was no significant difference in procedural success, major in-hospital complications or stroke at one year in patients undergoing transcatheter left atrial appendage occlusion (LAAO) with reduced LVEF; however, these patients did exhibit higher mortality at one year...
Sun Life extends collaboration with the American Diabetes Association to continue support of youth initiative Project Power mcarmody Tue, 06/30/2026 - 18:25 Press release Sun Life extends collaboration with the American Diabetes Association to continue support of youth initiative Project Power WELLESLEY, Mass. and MERRIFIELD, Va. June 29, 2026 Sun Life U.S. has renewed its national collaboration with the American Diabetes Association® (ADA), continuing its support of Project Power for youth, a comprehensive national initiative designed to engage, educate and empower young people to embrace…
Even with robust evidence demonstrating their efficacy and safety, direct oral anticoagulants (DOACs) continue to be underused and, at times, inappropriately dosed, particularly in patients at elevated thrombotic risk.
A new ACC Scientific Statement focused on the management of atherosclerotic cardiovascular disease, aims to help clinicians overcome the perpetual challenge of balancing the risk of ischemia with the risk of bleeding in this patient population.